Autori: Spigel David R
| Naslov | Reply to P. de Boissieu et al (Letter) |
| Autori | Spigel David R ... Chen Yuanbin Navarro Alejandro Chih Hsin Yang James Stojanovic Goran Jove Maria ... Andric Zoran G ... (broj koautora 17) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2025), vol. 43 br. 3, str. - |
| Projekat | Ipsen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (Article) |
| Autori | Spigel David R ... Stojanovic Goran ... Andric Zoran G ... (broj koautora 17) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2024), vol. 42 br. 19, str. - |
| Projekat | Ipsen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC (Meeting Abstract) |
| Autori | Spigel David R ... Andric Zoran G ... (broj koautora 20) |
| Info | ANNALS OF ONCOLOGY, (2019), vol. 30 br. , Suppl. 5, str. 915-915 |
| Projekat | F. Hoffmann-La RocheHoffmann-La Roche |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
